 |
 |
or buy their stock, anybody knows their stock symbol and what exchange it is traded at. ----- Original Message ----- From: "Kathleen Cochran" <[log in to unmask]> To: <[log in to unmask]> Sent: Monday, July 26, 2010 7:01 AM Subject: Re: GDNF making a comeback > Maybe we should all be raising money for Medgenesis. > > Kathleen > > On 24 July 2010 22:55, [log in to unmask] <[log in to unmask]> wrote: > >> Article from the Times Colonist, Victoria, Canada, 7/24/10 >> >> "Local biotech firm believes it's on the cusp of a brain breakthrough" >> >> is about MedGenesis, the Canadain biotech that managed to get the license >> from Amgen, after 4 years to further develop GDNF. They are using a >> convection enhanced delivery system, that allows the delivery of >> treatment >> via microscopic catheters, inserted through a patient's skull, into >> highly >> specific areas of brain tissue. >> >> . The company seems to be commited for GDNF to succeed,.As un-Amgen like >> as >> we could ever hope for. >> >> Excerpts:"According to MedGenesis CFO Michael Lincoln, the company is >> estimating the cost of getting GDNF through the trials and to market >> could >> be anywhere between $65 million and $100 million."Financing is always a >> key >> issue, and it was to our bad luck that the bottom fell out of the world >> economy at the time we needed to finance operations," said Mohr (CEO), >> who >> noted the company has managed through it because he had significant >> personal >> resources to draw on and a number of well-heeled contacts who bought into >> their plans. >> Mohr also pointed out his executive team stuck with the program. He took >> no >> salary for three years and his team worked for cut rates. >> Mohr said the fact his team remains intact is testament to the belief in >> what they are doing. >> "Our entire executive team is still at the table, nobody left," he said. >> "There is something there." >> "Mohr is hopeful they can begin Phase 2 clinical trials next year, a >> process expected to take about two years, including data analysis and >> dealing with Health Canada and the federal Food and Drug Administration >> in >> the U.S. >> "We're going to manufacture the product and go back into the clinic next >> year and we're very hopeful a pathway to success can be found," he said. >> Read full article >> http://www.timescolonist.com/health/Local+biotech+firm+believes+cusp+brain+breakthrough/3317850/story.html#ixzz0udpxbHyO >> >> >> >> --------- Forwarded Message ---------- >> From: "Stan" <[log in to unmask]> >> To: [log in to unmask] >> Subject: [pipelinerscore] GDNF "breakthrough" claimed >> Date: Sat, 24 Jul 2010 18:44:55 -0000 >> >> >> http://www.timescolonist.com/health/Local+biotech+firm+believes+cusp+brain+breakthrough/3317850/story.html >> >> >> ------------------------------------ >> >> Yahoo! Groups Links >> >> <*> To visit your group on the web, go to: >> http://groups.yahoo.com/group/pipelinerscore/ >> >> <*> Your email settings: >> Individual Email | Traditional >> >> <*> To change settings online go to: >> http://groups.yahoo.com/group/pipelinerscore/join >> (Yahoo! ID required) >> >> <*> To change settings via email: >> [log in to unmask] >> [log in to unmask] >> >> <*> To unsubscribe from this group, send an email to: >> [log in to unmask] >> >> <*> Your use of Yahoo! Groups is subject to: >> http://docs.yahoo.com/info/terms/ >> >> >> __._,_.___ >> >> Your email settings: Individual Email|Traditional >> Change settings via the Web (Yahoo! ID required) >> Change settings via email: Switch delivery to Daily Digest | Switch to >> Fully Featured >> Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe >> __,_._,___ >> >> ---------------------------------------------------------------------- >> To sign-off Parkinsn send a message to: mailto: >> [log in to unmask] >> In the body of the message put: signoff parkinsn >> > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: > mailto:[log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn